Stocks
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -151.1 | -207.3 | -194.4 | -179.4 | -179.4 | -154.3 | ||
| Changes by years, y/y, % | +97% | +37% | -6% | -8% | 0% | +32.6% | |||
Adaptive Biotechnologies. EBITDA US GAAP, bln rub
Adaptive Biotechnologies. EBITDA US GAAP, changes, %
Adaptive Biotechnologies. EBITDA US GAAP, sum by quarters, bln rub
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -51.0 | -40.2 | -40.2 | -39.3 | -34.4 | -154.3 | |
| Changes by years, y/y, % | +30% | +11% | +11% | -19% | -11% | |||
| Changes by quarters, q/q, % | +32% | -21% | 0% | -2% | -12% | |||
